Jode Goodridge

Title: Jode Goodridge: Innovator in Immunotherapy

Introduction

Jode Goodridge is a prominent inventor based in San Diego, California. He has made significant contributions to the field of immunotherapy, holding a total of five patents. His work focuses on enhancing immune effector cells through innovative methods and compositions.

Latest Patents

Goodridge's latest patents include "Enhanced immune effector cells and use thereof" and "Combining iPSC derived effector cell types for immunotherapy use." The first patent provides methods and compositions for obtaining functionally enhanced derivative effector cells derived from directed differentiation of genomically engineered induced pluripotent stem cells (iPSCs). These derivative cells exhibit stable and functional genome editing, delivering improved therapeutic effects. The second patent also outlines methods for obtaining enhanced effector cells and emphasizes their use in combination therapies with antibodies or checkpoint inhibitors.

Career Highlights

Jode Goodridge is currently associated with Fate Therapeutics, Inc., a company dedicated to developing innovative cell-based therapies. His work at Fate Therapeutics has positioned him as a key player in advancing immunotherapy solutions.

Collaborations

Goodridge collaborates with notable colleagues, including Bahram Valamehr and Ryan Bjordahl. Their combined expertise contributes to the innovative research and development efforts at Fate Therapeutics.

Conclusion

Jode Goodridge's contributions to immunotherapy through his patents and work at Fate Therapeutics highlight his role as a leading inventor in the field. His innovative approaches continue to pave the way for advancements in therapeutic applications.